Infant Clinical Nutrition

Infant Clinical Nutrition

Global Infant Clinical Nutrition Market to Reach US$43.3 Billion by 2030

The global market for Infant Clinical Nutrition estimated at US$31.0 Billion in the year 2023, is expected to reach US$43.3 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Milk-Based Infant Clinical Nutrition, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$27.2 Billion by the end of the analysis period. Growth in the Soy-Based Infant Clinical Nutrition segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.4 Billion While China is Forecast to Grow at 4.5% CAGR

The Infant Clinical Nutrition market in the U.S. is estimated at US$8.4 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Infant Clinical Nutrition Market - Key Trends & Drivers Summarized>What Is Infant Clinical Nutrition and Its Importance?

Infant clinical nutrition provides medically tailored dietary solutions for infants who have specific health needs, such as those born prematurely or with medical conditions that affect their ability to consume regular infant formula. This specialized nutrition is crucial for the proper growth and development of these infants, offering tailored macronutrient and micronutrient compositions to meet their unique health requirements. The importance of clinical nutrition in early life stages is underscored by the need to support optimal developmental outcomes, particularly in infants who require additional nutritional support to thrive.

How Is the Field of Infant Clinical Nutrition Evolving?

The field of infant clinical nutrition is rapidly evolving with advances in medical and nutritional sciences. Research into the unique nutritional needs of medically fragile infants has led to the development of formulas and feeding solutions that closely mimic human breast milk, which is considered the gold standard for infant nutrition. Innovations include the incorporation of human milk oligosaccharides, which are crucial for immune system development and gut health. Furthermore, the growing understanding of the microbiome`s role in early childhood development is influencing product formulations to include prebiotics and probiotics to support gut health and immune function.

What Market Trends Are Driving Demand for Infant Clinical Nutrition?

The market for infant clinical nutrition is driven by several trends, including the increasing incidence of preterm births and the growing awareness and diagnosis of food allergies and metabolic disorders in infants. These trends necessitate specialized dietary formulations to meet the heightened nutritional requirements of these infants. Additionally, healthcare providers and parents are becoming more knowledgeable about the potential long-term health impacts of early nutritional interventions, which is increasing demand for these products. The trend towards personalized medicine is also extending into pediatric nutrition, influencing the development of more targeted and effective nutritional therapies.

Growth in the Infant Clinical Nutrition Market Is Driven by Several Factors

The growth in the infant clinical nutrition market is driven by several factors, including advancements in medical research that enhance understanding of infant nutritional needs and the development of new products that address these needs more effectively. The increasing prevalence of conditions that require specialized nutrition solutions, such as allergies and preterm births, also significantly contributes to market growth. Additionally, global initiatives to improve neonatal care and nutritional outcomes are promoting the use of advanced clinical nutrition products. The rising investment in healthcare infrastructure and services around the world supports the accessibility and adoption of these specialized nutritional solutions, further driving market expansion.

Select Competitors (Total 46 Featured) -

• Abbott Laboratories
• B. Braun Melsungen AG
• Baxter International, Inc.
• Claris Lifesciences Ltd.
• Fresenius Kabi AG
• Groupe Danone
• Mead Johnson Nutrition Company
• Meiji Co., Ltd.
• Nestle Health Science SA
• Nutricia North America

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.